CU Innovations Annual Report 2025
Showcasing a Year of Innovations
We collaborate with visionary startups and faculty innovators to accelerate breakthroughs in patient care. This year’s report highlights transformative work in precision medicine, data-driven drug development, and clinical trial innovation. Featured startups include OncoVerity, RefinedScience, Spyglass Pharma, Q32 Bio, Arrive Health and Amplifire.
Our Mission and Services
CU Innovations specializes in commercializing technology, developing ventures, and building business partnerships. Located on the University of Colorado Anschutz, we are the go-to resource for biomedical technology commercialization. By uniting industry partners, entrepreneurs, and investors, we assist CU researchers in developing biomedical technologies - improving the quality of life for patients worldwide.